Advanced Proteome Therapeutics Corp (APTCF)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
Advanced Proteome Therapeutics Research and Development Expense (Quarterly): 0.0854M for April 30, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2023 | 0.0854M |
| January 31, 2023 | 0.1671M |
| October 31, 2022 | 0.1756M |
| July 31, 2022 | 0.1671M |
| April 30, 2022 | 0.1616M |
| January 31, 2022 | 0.1883M |
| October 31, 2021 | 0.1705M |
| July 31, 2021 | |
| April 30, 2021 | |
| January 31, 2021 | |
| October 31, 2020 | |
| July 31, 2020 | |
| April 30, 2020 | |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | |
| April 30, 2019 | |
| January 31, 2019 | |
| October 31, 2018 | |
| July 31, 2018 | |
| April 30, 2018 | |
| January 31, 2018 | |
| October 31, 2017 | |
| July 31, 2017 | |
| April 30, 2017 |
| Date | Value |
|---|---|
| January 31, 2017 | |
| October 31, 2016 | |
| July 31, 2016 | |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | |
| April 30, 2015 | |
| January 31, 2015 | |
| October 31, 2014 | |
| July 31, 2014 | |
| April 30, 2014 | |
| January 31, 2014 | |
| October 31, 2013 | |
| July 31, 2013 | |
| April 30, 2013 | |
| January 31, 2013 | |
| October 31, 2012 | |
| July 31, 2012 | |
| April 30, 2012 | |
| January 31, 2012 | |
| October 31, 2011 | |
| July 31, 2011 | |
| April 30, 2011 | |
| January 31, 2011 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.0854M
Minimum
Apr 2023
0.1883M
Maximum
Jan 2022
0.1594M
Average
0.1671M
Median
Jan 2023
Research and Development Expense (Quarterly) Benchmarks
| Cotinga Pharmaceuticals Inc | 0.1096M |
| Avitar Inc | -- |
| Acasti Pharma Inc | 1.443M |
| Aurinia Pharmaceuticals Inc | 10.23M |
| Edesa Biotech Inc | 0.7045M |